{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T19:39:28Z","timestamp":1783107568477,"version":"3.54.6"},"reference-count":114,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2025,4,17]],"date-time":"2025-04-17T00:00:00Z","timestamp":1744848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,4,17]],"date-time":"2025-04-17T00:00:00Z","timestamp":1744848000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Pharmacol Sin"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1038\/s41401-025-01554-2","type":"journal-article","created":{"date-parts":[[2025,4,17]],"date-time":"2025-04-17T06:32:46Z","timestamp":1744871566000},"page":"2587-2596","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Immune cells in systemic lupus erythematosus: biology and traditional Chinese medicine therapy"],"prefix":"10.1038","volume":"46","author":[{"given":"Ya-nan","family":"Liang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luo","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing-yu","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-ting","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-juan","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tong-qing","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia-hui","family":"Ni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-yan","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-ming","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"You","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,17]]},"reference":[{"key":"1554_CR1","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1136\/annrheumdis-2018-214819","volume":"78","author":"M Aringer","year":"2019","unstructured":"Aringer M, Costenbader K, Daikh D, Brinks R, Mosca M, Ramsey-Goldman R, et al. 2019 European League Against Rheumatism\/American College of Rheumatology classification criteria for systemic lupus erythematosus. Ann Rheum Dis. 2019;78:1151\u20139.","journal-title":"Ann Rheum Dis"},{"key":"1554_CR2","doi-asserted-by":"publisher","first-page":"2110","DOI":"10.1056\/NEJMra1100359","volume":"365","author":"GC Tsokos","year":"2011","unstructured":"Tsokos GC. Systemic lupus erythematosus. N Engl J Med. 2011;365:2110\u201321.","journal-title":"N Engl J Med"},{"key":"1554_CR3","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1038\/s41584-021-00668-1","volume":"17","author":"MRW Barber","year":"2021","unstructured":"Barber MRW, Drenkard C, Falasinnu T, Hoi A, Mak A, Kow NY, et al. Global epidemiology of systemic lupus erythematosus. Nat Rev Rheumatol. 2021;17:515\u201332.","journal-title":"Nat Rev Rheumatol"},{"key":"1554_CR4","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1038\/nrneph.2015.33","volume":"11","author":"C Mohan","year":"2015","unstructured":"Mohan C, Putterman C. Genetics and pathogenesis of systemic lupus erythematosus and lupus nephritis. Nat Rev Nephrol. 2015;11:329\u201341.","journal-title":"Nat Rev Nephrol"},{"key":"1554_CR5","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1038\/s41590-020-0677-6","volume":"21","author":"GC Tsokos","year":"2020","unstructured":"Tsokos GC. Autoimmunity and organ damage in systemic lupus erythematosus. Nat Immunol. 2020;21:605\u201314.","journal-title":"Nat Immunol"},{"key":"1554_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jaut.2018.11.001","volume":"96","author":"A Fava","year":"2019","unstructured":"Fava A, Petri M. Systemic lupus erythematosus: diagnosis and clinical management. J Autoimmun. 2019;96:1\u201313.","journal-title":"J Autoimmun"},{"key":"1554_CR7","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1136\/ard-2023-224762","volume":"83","author":"A Fanouriakis","year":"2024","unstructured":"Fanouriakis A, Kostopoulou M, Andersen J, Aringer M, Arnaud L, Bae SC, et al. EULAR recommendations for the management of systemic lupus erythematosus: 2023 update. Ann Rheum Dis. 2024;83:15\u201329.","journal-title":"Ann Rheum Dis"},{"key":"1554_CR8","doi-asserted-by":"publisher","first-page":"107452","DOI":"10.1016\/j.pharmthera.2019.107452","volume":"207","author":"L Zhang","year":"2020","unstructured":"Zhang L, Wei W. Anti-inflammatory and immunoregulatory effects of paeoniflorin and total glucosides of paeony. Pharmacol Ther. 2020;207:107452.","journal-title":"Pharmacol Ther"},{"key":"1554_CR9","first-page":"249","volume":"73","author":"SC Buessow","year":"1984","unstructured":"Buessow SC, Paul RD, Lopez DM. Influence of mammary tumor progression on phenotype and function of spleen and in situ lymphocytes in mice. J Natl Cancer Inst. 1984;73:249\u201355.","journal-title":"J Natl Cancer Inst"},{"key":"1554_CR10","first-page":"100","volume":"47","author":"MR Young","year":"1987","unstructured":"Young MR, Newby M, Wepsic HT. Hematopoiesis and suppressor bone marrow cells in mice bearing large metastatic Lewis lung carcinoma tumors. Cancer Res. 1987;47:100\u20135.","journal-title":"Cancer Res"},{"key":"1554_CR11","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1038\/nri2506","volume":"9","author":"DI Gabrilovich","year":"2009","unstructured":"Gabrilovich DI, Nagaraj S. Myeloid-derived suppressor cells as regulators of the immune system. Nat Rev Immunol. 2009;9:162\u201374.","journal-title":"Nat Rev Immunol"},{"key":"1554_CR12","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1158\/0008-5472.CAN-09-2587","volume":"70","author":"MK Srivastava","year":"2010","unstructured":"Srivastava MK, Sinha P, Clements VK, Rodriguez P, Ostrand-Rosenberg S. Myeloid-derived suppressor cells inhibit T-cell activation by depleting cystine and cysteine. Cancer Res. 2010;70:68\u201377.","journal-title":"Cancer Res"},{"key":"1554_CR13","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1016\/S1471-4906(03)00132-7","volume":"24","author":"V Bronte","year":"2003","unstructured":"Bronte V, Serafini P, Mazzoni A, Segal DM, Zanovello P. L-arginine metabolism in myeloid cells controls T-lymphocyte functions. Trends Immunol. 2003;24:302\u20136.","journal-title":"Trends Immunol"},{"key":"1554_CR14","doi-asserted-by":"publisher","first-page":"4499","DOI":"10.4049\/jimmunol.0802740","volume":"182","author":"S Ostrand-Rosenberg","year":"2009","unstructured":"Ostrand-Rosenberg S, Sinha P. Myeloid-derived suppressor cells: linking inflammation and cancer. J Immunol. 2009;182:4499\u2013506.","journal-title":"J Immunol"},{"key":"1554_CR15","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms12150","volume":"7","author":"V Bronte","year":"2016","unstructured":"Bronte V, Brandau S, Chen SH, Colombo MP, Frey AB, Greten TF, et al. Recommendations for myeloid-derived suppressor cell nomenclature and characterization standards. Nat Commun. 2016;7:12150.","journal-title":"Nat Commun"},{"key":"1554_CR16","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1016\/j.humimm.2016.05.024","volume":"77","author":"P Boros","year":"2016","unstructured":"Boros P, Ochando J, Zeher M. Myeloid derived suppressor cells and autoimmunity. Hum Immunol. 2016;77:631\u20136.","journal-title":"Hum Immunol"},{"key":"1554_CR17","doi-asserted-by":"publisher","first-page":"5537","DOI":"10.1172\/JCI129502","volume":"129","author":"H Mohammadpour","year":"2019","unstructured":"Mohammadpour H, MacDonald CR, Qiao G, Chen M, Dong B, Hylander BL, et al. \u03b22 adrenergic receptor-mediated signaling regulates the immunosuppressive potential of myeloid-derived suppressor cells. J Clin Invest. 2019;129:5537\u201352.","journal-title":"J Clin Invest"},{"key":"1554_CR18","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1038\/s41577-020-00490-y","volume":"21","author":"F Veglia","year":"2021","unstructured":"Veglia F, Sanseviero E, Gabrilovich DI. Myeloid-derived suppressor cells in the era of increasing myeloid cell diversity. Nat Rev Immunol. 2021;21:485\u201398.","journal-title":"Nat Rev Immunol"},{"key":"1554_CR19","doi-asserted-by":"publisher","first-page":"2717","DOI":"10.1002\/art.39767","volume":"68","author":"MJ Park","year":"2016","unstructured":"Park MJ, Lee SH, Kim EK, Lee EJ, Park SH, Kwok SK, et al. Myeloid-derived suppressor cells induce the expansion of regulatory B cells and ameliorate autoimmunity in the Sanroque mouse model of systemic lupus erythematosus. Arthritis Rheumatol. 2016;68:2717\u201327.","journal-title":"Arthritis Rheumatol"},{"key":"1554_CR20","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1002\/art.38259","volume":"66","author":"EV Louren\u00e7o","year":"2014","unstructured":"Louren\u00e7o EV, Wong M, Hahn BH, Palma-Diaz MF, Skaggs BJ. Laquinimod delays and suppresses nephritis in lupus-prone mice and affects both myeloid and lymphoid immune cells. Arthritis Rheumatol. 2014;66:674\u201385.","journal-title":"Arthritis Rheumatol"},{"key":"1554_CR21","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1038\/s41423-019-0271-8","volume":"16","author":"J Ji","year":"2019","unstructured":"Ji J, Li P, Shen C, Dou H, Wang T, Shi L, et al. MDSCs: friend or foe in systemic lupus erythematosus. Cell Mol Immunol. 2019;16:937\u20139.","journal-title":"Cell Mol Immunol"},{"key":"1554_CR22","doi-asserted-by":"publisher","first-page":"331ra40","DOI":"10.1126\/scitranslmed.aae0482","volume":"8","author":"H Wu","year":"2016","unstructured":"Wu H, Zhen Y, Ma Z, Li H, Yu J, Xu ZG, et al. Arginase-1-dependent promotion of TH17 differentiation and disease progression by MDSCs in systemic lupus erythematosus. Sci Transl Med. 2016;8:331ra40.","journal-title":"Sci Transl Med"},{"key":"1554_CR23","doi-asserted-by":"publisher","first-page":"2209","DOI":"10.1042\/CS20200799","volume":"134","author":"B Pang","year":"2020","unstructured":"Pang B, Zhen Y, Hu C, Ma Z, Lin S, Yi H. Myeloid-derived suppressor cells shift Th17\/Treg ratio and promote systemic lupus erythematosus progression through arginase-1\/miR-322-5p\/TGF-\u03b2 pathway. Clin Sci. 2020;134:2209\u201322.","journal-title":"Clin Sci"},{"key":"1554_CR24","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1016\/j.ymthe.2022.10.013","volume":"31","author":"C Hu","year":"2023","unstructured":"Hu C, Zhen Y, Ma Z, Zhao L, Wu H, Shu C, et al. Polyamines from myeloid-derived suppressor cells promote Th17 polarization and disease progression. Mol Ther. 2023;31:569\u201384.","journal-title":"Mol Ther"},{"key":"1554_CR25","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-021-04052-5","volume":"12","author":"D Li","year":"2021","unstructured":"Li D, Lu L, Kong W, Xia X, Pan Y, Li J, et al. C-type lectin receptor Dectin3 deficiency balances the accumulation and function of FoxO1-mediated LOX-1+ M-MDSCs in relieving lupus-like symptoms. Cell Death Dis. 2021;12:829.","journal-title":"Cell Death Dis"},{"key":"1554_CR26","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1111\/imm.13570","volume":"168","author":"X Li","year":"2023","unstructured":"Li X, Fei F, Yao G, Yang X, Geng L, Wang D, et al. Notch1 signalling controls the differentiation and function of myeloid-derived suppressor cells in systemic lupus erythematosus. Immunology. 2023;168:170\u201383.","journal-title":"Immunology"},{"key":"1554_CR27","doi-asserted-by":"publisher","first-page":"2118","DOI":"10.1038\/s42255-024-01149-x","volume":"6","author":"X Zhang","year":"2024","unstructured":"Zhang X, Chen Y, Sun G, Fei Y, Zhu H, Liu Y, et al. Farnesyl pyrophosphate potentiates dendritic cell migration in autoimmunity through mitochondrial remodelling. Nat Metab. 2024;6:2118\u201337.","journal-title":"Nat Metab"},{"key":"1554_CR28","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1002\/eji.201040767","volume":"41","author":"Y Zhang","year":"2011","unstructured":"Zhang Y, Liu S, Yu Y, Zhang T, Liu J, Shen Q, et al. Immune complex enhances tolerogenecity of immature dendritic cells via Fc\u03b3RIIb and promotes Fc\u03b3RIIb-overexpressing dendritic cells to attenuate lupus. Eur J Immunol. 2011;41:1154\u201364.","journal-title":"Eur J Immunol"},{"key":"1554_CR29","doi-asserted-by":"publisher","first-page":"3785","DOI":"10.1021\/acs.jmedchem.9b01039","volume":"63","author":"H Zhang","year":"2020","unstructured":"Zhang H, You QD, Xu XL. Targeting stimulator of interferon genes (STING): a medicinal chemistry perspective. J Med Chem. 2020;63:3785\u2013816.","journal-title":"J Med Chem"},{"key":"1554_CR30","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1016\/j.immuni.2019.08.008","volume":"51","author":"CA Dutertre","year":"2019","unstructured":"Dutertre CA, Becht E, Irac SE, Khalilnezhad A, Narang V, Khalilnezhad S, et al. Single-cell analysis of human mononuclear phagocytes reveals subset-defining markers and identifies circulating inflammatory dendritic cells. Immunity. 2019;51:573\u201389.e8.","journal-title":"Immunity"},{"key":"1554_CR31","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2021.636188","volume":"8","author":"X Song","year":"2021","unstructured":"Song X, Zhang H, Zhao Y, Lin Y, Tang Q, Zhou X, et al. HMGB1 activates myeloid dendritic cells by up-regulating mTOR pathway in systemic lupus erythematosus. Front Med. 2021;8:636188.","journal-title":"Front Med"},{"key":"1554_CR32","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1172\/JCI124466","volume":"129","author":"R Furie","year":"2019","unstructured":"Furie R, Werth VP, Merola JF, Stevenson L, Reynolds TL, Naik H, et al. Monoclonal antibody targeting BDCA2 ameliorates skin lesions in systemic lupus erythematosus. J Clin Invest. 2019;129:1359\u201371.","journal-title":"J Clin Invest"},{"key":"1554_CR33","doi-asserted-by":"publisher","first-page":"2106","DOI":"10.1002\/art.41419","volume":"72","author":"J Li","year":"2020","unstructured":"Li J, Ding H, Meng Y, Li G, Fu Q, Guo Q, et al. Taurine metabolism aggravates the progression of lupus by promoting the function of plasmacytoid dendritic cells. Arthritis Rheumatol. 2020;72:2106\u201317.","journal-title":"Arthritis Rheumatol"},{"key":"1554_CR34","doi-asserted-by":"publisher","first-page":"2514","DOI":"10.1016\/j.immuni.2021.10.009","volume":"54","author":"KM Grzes","year":"2021","unstructured":"Grzes KM, Sanin DE, Kabat AM, Stanczak MA, Edwards-Hicks J, Matsushita M, et al. Plasmacytoid dendritic cell activation is dependent on coordinated expression of distinct amino acid transporters. Immunity. 2021;54:2514\u201330.e7.","journal-title":"Immunity"},{"key":"1554_CR35","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1038\/s41590-020-0731-4","volume":"21","author":"A Abbas","year":"2020","unstructured":"Abbas A, Vu Manh TP, Valente M, Collinet N, Attaf N, Dong C, et al. The activation trajectory of plasmacytoid dendritic cells in vivo during a viral infection. Nat Immunol. 2020;21:983\u201397.","journal-title":"Nat Immunol"},{"key":"1554_CR36","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1007\/s12031-015-0643-1","volume":"57","author":"M Abdolahi","year":"2015","unstructured":"Abdolahi M, Yavari P, Honarvar NM, Bitarafan S, Mahmoudi M, Saboor-Yaraghi AA. Molecular mechanisms of the action of vitamin A in Th17\/Treg axis in multiple sclerosis. J Mol Neurosci. 2015;57:605\u201313.","journal-title":"J Mol Neurosci"},{"key":"1554_CR37","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1016\/j.autrev.2019.02.006","volume":"18","author":"SC Funes","year":"2019","unstructured":"Funes SC, Manrique de Lara A, Altamirano-Lagos MJ, Mackern-Oberti JP, Escobar-Vera J, Kalergis AM. Immune checkpoints and the regulation of tolerogenicity in dendritic cells: Implications for autoimmunity and immunotherapy. Autoimmun Rev. 2019;18:359\u201368.","journal-title":"Autoimmun Rev"},{"key":"1554_CR38","doi-asserted-by":"publisher","first-page":"1598","DOI":"10.3389\/fimmu.2017.01598","volume":"8","author":"JS Suwandi","year":"2017","unstructured":"Suwandi JS, Nikolic T, Roep BO. Translating mechanism of regulatory action of tolerogenic dendritic cells to monitoring endpoints in clinical trials. Front Immunol. 2017;8:1598.","journal-title":"Front Immunol"},{"key":"1554_CR39","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-10491-8","volume":"10","author":"X Yuan","year":"2019","unstructured":"Yuan X, Qin X, Wang D, Zhang Z, Tang X, Gao X, et al. Mesenchymal stem cell therapy induces FLT3L and CD1c+ dendritic cells in systemic lupus erythematosus patients. Nat Commun. 2019;10:2498.","journal-title":"Nat Commun"},{"key":"1554_CR40","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1111\/imm.13119","volume":"158","author":"SC Funes","year":"2019","unstructured":"Funes SC, R\u00edos M, G\u00f3mez-Santander F, Fern\u00e1ndez-Fierro A, Altamirano-Lagos MJ, Rivera-Perez D, et al. Tolerogenic dendritic cell transfer ameliorates systemic lupus erythematosus in mice. Immunology. 2019;158:322\u201339.","journal-title":"Immunology"},{"key":"1554_CR41","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.cellimm.2017.12.010","volume":"324","author":"U De la Cruz-Mosso","year":"2018","unstructured":"De la Cruz-Mosso U, Garc\u00eda-Iglesias T, Bucala R, Estrada-Garc\u00eda I, Gonz\u00e1lez-L\u00f3pez L, Cerpa-Cruz S, et al. MIF promotes a differential Th1\/Th2\/Th17 inflammatory response in human primary cell cultures: Predominance of Th17 cytokine profile in PBMC from healthy subjects and increase of IL-6 and TNF-\u03b1 in PBMC from active SLE patients. Cell Immunol. 2018;324:42\u20139.","journal-title":"Cell Immunol"},{"key":"1554_CR42","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.clim.2018.08.005","volume":"195","author":"A Tsanaktsi","year":"2018","unstructured":"Tsanaktsi A, Solomou EE, Liossis SC. Th1\/17 cells, a subset of Th17 cells, are expanded in patients with active systemic lupus erythematosus. Clin Immunol. 2018;195:101\u20136.","journal-title":"Clin Immunol"},{"key":"1554_CR43","doi-asserted-by":"crossref","unstructured":"Kaul A, Gordon C, Crow MK, Touma Z, Urowitz MB, van Vollenhoven R, et al. Systemic lupus erythematosus. Nat Rev Dis Primers. 2016;2:16039.","DOI":"10.1038\/nrdp.2016.39"},{"key":"1554_CR44","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1002\/eji.201344280","volume":"45","author":"K Ohl","year":"2015","unstructured":"Ohl K, Tenbrock K. Regulatory T cells in systemic lupus erythematosus. Eur J Immunol. 2015;45:344\u201355.","journal-title":"Eur J Immunol"},{"key":"1554_CR45","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.1111\/1346-8138.15899","volume":"48","author":"M Li","year":"2021","unstructured":"Li M, Yu D, Wang Y, Luo N, Han G, Yang B. Interferon-\u03b1 activates interleukin-1 receptor-associated kinase 1 to induce regulatory T-cell apoptosis in patients with systemic lupus erythematosus. J Dermatol. 2021;48:1172\u201385.","journal-title":"J Dermatol"},{"key":"1554_CR46","doi-asserted-by":"crossref","unstructured":"Scherlinger M, Guillotin V, Douchet I, Vacher P, Boizard-Moracchini A, Guegan JP, et al. Selectins impair regulatory T cell function and contribute to systemic lupus erythematosus pathogenesis. Sci Transl Med. 2021;13:eabi4994.","DOI":"10.1126\/scitranslmed.abi4994"},{"key":"1554_CR47","doi-asserted-by":"publisher","first-page":"106139","DOI":"10.1016\/j.intimp.2019.106139","volume":"80","author":"B Du","year":"2020","unstructured":"Du B, Fan X, Lei F, Zhang S, Li G, Xi X. Comparative transcriptome analysis reveals a potential role for CaMK4 in \u03b3\u03b4T17 cells from systemic lupus erythematosus patients with lupus nephritis. Int Immunopharmacol. 2020;80:106139.","journal-title":"Int Immunopharmacol"},{"key":"1554_CR48","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adc9657","volume":"8","author":"M Scherlinger","year":"2022","unstructured":"Scherlinger M, Pan W, Hisada R, Boulougoura A, Yoshida N, Vukelic M, et al. Phosphofructokinase P fine-tunes T regulatory cell metabolism, function, and stability in systemic autoimmunity. Sci Adv. 2022;8:eadc9657.","journal-title":"Sci Adv"},{"key":"1554_CR49","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1002\/art.40785","volume":"71","author":"T Koga","year":"2019","unstructured":"Koga T, Sato T, Furukawa K, Morimoto S, Endo Y, Umeda M, et al. Promotion of calcium\/calmodulin-dependent protein kinase 4 by GLUT1-dependent glycolysis in systemic lupus erythematosus. Arthritis Rheumatol. 2019;71:766\u201372.","journal-title":"Arthritis Rheumatol"},{"key":"1554_CR50","doi-asserted-by":"publisher","first-page":"114379","DOI":"10.1016\/j.celrep.2024.114379","volume":"43","author":"W Pan","year":"2024","unstructured":"Pan W, Tsokos MG, Scherlinger M, Li W, Tsokos GC. The PP2A regulatory subunit PPP2R2A controls NAD+ biosynthesis to regulate T cell subset differentiation in systemic autoimmunity. Cell Rep. 2024;43:114379.","journal-title":"Cell Rep"},{"key":"1554_CR51","first-page":"516","volume":"56","author":"N Gensous","year":"2017","unstructured":"Gensous N, Schmitt N, Richez C, Ueno H, Blanco P. T follicular helper cells, interleukin-21 and systemic lupus erythematosus. Rheumatology. 2017;56:516\u201323.","journal-title":"Rheumatology"},{"key":"1554_CR52","doi-asserted-by":"publisher","DOI":"10.1186\/s13148-021-01007-7","volume":"13","author":"L Liu","year":"2021","unstructured":"Liu L, Hu L, Yang L, Jia S, Du P, Min X, et al. UHRF1 downregulation promotes T follicular helper cell differentiation by increasing BCL6 expression in SLE. Clin Epigenetics. 2021;13:31.","journal-title":"Clin Epigenetics"},{"key":"1554_CR53","doi-asserted-by":"publisher","first-page":"1603","DOI":"10.1016\/j.immuni.2024.04.023","volume":"57","author":"X Li","year":"2024","unstructured":"Li X, Sun W, Huang M, Gong L, Zhang X, Zhong L, et al. Deficiency of CBL and CBLB ubiquitin ligases leads to hyper T follicular helper cell responses and lupus by reducing BCL6 degradation. Immunity. 2024;57:1603\u201317.e7.","journal-title":"Immunity"},{"key":"1554_CR54","doi-asserted-by":"publisher","first-page":"102976","DOI":"10.1016\/j.jaut.2022.102976","volume":"134","author":"X Wei","year":"2023","unstructured":"Wei X, Niu X. T follicular helper cells in autoimmune diseases. J Autoimmun. 2023;134:102976.","journal-title":"J Autoimmun"},{"key":"1554_CR55","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1038\/s41586-021-03692-z","volume":"595","author":"G Fu","year":"2021","unstructured":"Fu G, Guy CS, Chapman NM, Palacios G, Wei J, Zhou P, et al. Metabolic control of T(FH) cells and humoral immunity by phosphatidylethanolamine. Nature. 2021;595:724\u20139.","journal-title":"Nature"},{"key":"1554_CR56","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1038\/s41584-019-0356-x","volume":"16","author":"A Sharabi","year":"2020","unstructured":"Sharabi A, Tsokos GC. T cell metabolism: new insights in systemic lupus erythematosus pathogenesis and therapy. Nat Rev Rheumatol. 2020;16:100\u201312.","journal-title":"Nat Rev Rheumatol"},{"key":"1554_CR57","doi-asserted-by":"publisher","first-page":"2828","DOI":"10.1182\/blood-2004-07-2583","volume":"105","author":"K Fischer","year":"2005","unstructured":"Fischer K, Voelkl S, Heymann J, Przybylski GK, Mondal K, Laumer M, et al. Isolation and characterization of human antigen-specific TCR alpha beta+ CD4-CD8- double-negative regulatory T cells. Blood. 2005;105:2828\u201335.","journal-title":"Blood"},{"key":"1554_CR58","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1189\/jlb.3RU0914-443R","volume":"97","author":"S Paul","year":"2015","unstructured":"Paul S, Shilpi, Lal G. Role of gamma-delta (\u03b3\u03b4) T cells in autoimmunity. J Leukoc Biol. 2015;97:259\u201371.","journal-title":"J Leukoc Biol"},{"key":"1554_CR59","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.1002\/art.40524","volume":"70","author":"YJ Lee","year":"2018","unstructured":"Lee YJ, Park JA, Kwon H, Choi YS, Jung KC, Park SH, et al. Role of stem cell-like memory T cells in systemic lupus erythematosus. Arthritis Rheumatol. 2018;70:1459\u201369.","journal-title":"Arthritis Rheumatol"},{"key":"1554_CR60","doi-asserted-by":"publisher","first-page":"2097","DOI":"10.1002\/1529-0131(200109)44:9<2097::AID-ART360>3.0.CO;2-6","volume":"44","author":"K Masutani","year":"2001","unstructured":"Masutani K, Akahoshi M, Tsuruya K, Tokumoto M, Ninomiya T, Kohsaka T, et al. Predominance of Th1 immune response in diffuse proliferative lupus nephritis. Arthritis Rheum. 2001;44:2097\u2013106.","journal-title":"Arthritis Rheum"},{"key":"1554_CR61","doi-asserted-by":"publisher","first-page":"2263","DOI":"10.1681\/ASN.2019090937","volume":"31","author":"W Chen","year":"2020","unstructured":"Chen W, Li W, Zhang Z, Tang X, Wu S, Yao G, et al. Lipocalin-2 exacerbates lupus nephritis by promoting Th1 cell differentiation. J Am Soc Nephrol. 2020;31:2263\u201377.","journal-title":"J Am Soc Nephrol"},{"key":"1554_CR62","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1038\/s41392-023-01709-9","volume":"9","author":"Y Zhang","year":"2024","unstructured":"Zhang Y, Du L, Wang C, Jiang Z, Duan Q, Li Y, et al. Neddylation is a novel therapeutic target for lupus by regulating double negative T cell homeostasis. Signal Transduct Target Ther. 2024;9:18.","journal-title":"Signal Transduct Target Ther"},{"key":"1554_CR63","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1038\/nrrheum.2010.68","volume":"6","author":"I Sanz","year":"2010","unstructured":"Sanz I, Lee FE. B cells as therapeutic targets in SLE. Nat Rev Rheumatol. 2010;6:326\u201337.","journal-title":"Nat Rev Rheumatol"},{"key":"1554_CR64","doi-asserted-by":"publisher","first-page":"626820","DOI":"10.3389\/fimmu.2020.626820","volume":"11","author":"K Bhamidipati","year":"2020","unstructured":"Bhamidipati K, Silberstein JL, Chaichian Y, Baker MC, Lanz TV, Zia A, et al. CD52 is elevated on B cells of SLE patients and regulates B cell function. Front Immunol. 2020;11:626820.","journal-title":"Front Immunol"},{"key":"1554_CR65","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abo5840","volume":"8","author":"T Manolakou","year":"2022","unstructured":"Manolakou T, Nikolopoulos D, Gkikas D, Filia A, Samiotaki M, Stamatakis G, et al. ATR-mediated DNA damage responses underlie aberrant B cell activity in systemic lupus erythematosus. Sci Adv. 2022;8:eabo5840.","journal-title":"Sci Adv"},{"key":"1554_CR66","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1235937","volume":"14","author":"JA \u00c1lvarez G\u00f3mez","year":"2023","unstructured":"\u00c1lvarez G\u00f3mez JA, Salazar-Camarena DC, Rom\u00e1n-Fern\u00e1ndez IV, Ortiz-Lazareno PC, Cruz A, Mu\u00f1oz-Valle JF, et al. BAFF system expression in double negative 2, activated na\u00efve and activated memory B cells in systemic lupus erythematosus. Front Immunol. 2023;14:1235937.","journal-title":"Front Immunol"},{"key":"1554_CR67","doi-asserted-by":"publisher","first-page":"1790","DOI":"10.1016\/j.cell.2021.02.015","volume":"184","author":"B Yu","year":"2021","unstructured":"Yu B, Qi Y, Li R, Shi Q, Satpathy AT, Chang HY. B cell-specific XIST complex enforces X-inactivation and restrains atypical B cells. Cell. 2021;184:1790\u2013803.e17.","journal-title":"Cell"},{"key":"1554_CR68","doi-asserted-by":"crossref","unstructured":"Pyfrom S, Paneru B, Knox JJ, Cancro MP, Posso S, Buckner JH, et al. The dynamic epigenetic regulation of the inactive X chromosome in healthy human B cells is dysregulated in lupus patients. Proc Natl Acad Sci USA. 2021;118:e2024624118.","DOI":"10.1073\/pnas.2024624118"},{"key":"1554_CR69","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1038\/s41590-024-01798-w","volume":"25","author":"HF Bradford","year":"2024","unstructured":"Bradford HF, McDonnell TCR, Stewart A, Skelton A, Ng J, Baig Z, et al. Thioredoxin is a metabolic rheostat controlling regulatory B cells. Nat Immunol. 2024;25:873\u201385.","journal-title":"Nat Immunol"},{"key":"1554_CR70","doi-asserted-by":"publisher","first-page":"1869","DOI":"10.3389\/fimmu.2018.01869","volume":"9","author":"AM Abel","year":"2018","unstructured":"Abel AM, Yang C, Thakar MS, Malarkannan S. Natural killer cells: development, maturation, and clinical utilization. Front Immunol. 2018;9:1869.","journal-title":"Front Immunol"},{"key":"1554_CR71","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-62325-3","volume":"14","author":"A Radziszewska","year":"2024","unstructured":"Radziszewska A, Peckham H, de Gruijter NM, Restuadi R, Wu WH, Jury EC, et al. Active juvenile systemic lupus erythematosus is associated with distinct NK cell transcriptional and phenotypic alterations. Sci Rep. 2024;14:13074.","journal-title":"Sci Rep"},{"key":"1554_CR72","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1159\/000430251","volume":"37","author":"F Li","year":"2015","unstructured":"Li F, Yang Y, Zhu X, Huang L, Xu J. Macrophage polarization modulates development of systemic lupus erythematosus. Cell Physiol Biochem. 2015;37:1279\u201388.","journal-title":"Cell Physiol Biochem"},{"key":"1554_CR73","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.734008","volume":"12","author":"MM Ahamada","year":"2021","unstructured":"Ahamada MM, Jia Y, Wu X. Macrophage polarization and plasticity in systemic lupus erythematosus. Front Immunol. 2021;12:734008.","journal-title":"Front Immunol"},{"key":"1554_CR74","doi-asserted-by":"crossref","unstructured":"Yang S, Du P, Cui H, Zheng M, He W, Gao X, et al. Regulatory factor X1 induces macrophage M1 polarization by promoting DNA demethylation in autoimmune inflammation. JCI Insight 2023;8:e165546.","DOI":"10.1172\/jci.insight.165546"},{"key":"1554_CR75","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s41927-023-00358-3","volume":"7","author":"J Chan","year":"2023","unstructured":"Chan J, Walters GD, Puri P, Jiang SH. Safety and efficacy of biological agents in the treatment of Systemic Lupus Erythematosus (SLE). BMC Rheumatol. 2023;7:37.","journal-title":"BMC Rheumatol"},{"key":"1554_CR76","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1002\/art.41683","volume":"73","author":"JT Rosenbaum","year":"2021","unstructured":"Rosenbaum JT, Costenbader KH, Desmarais J, Ginzler EM, Fett N, Goodman SM, et al. American College of Rheumatology, American Academy of Dermatology, Rheumatologic Dermatology Society, and American Academy of Ophthalmology 2020 Joint Statement on hydroxychloroquine use with respect to retinal toxicity. Arthritis Rheumatol. 2021;73:908\u201311.","journal-title":"Arthritis Rheumatol"},{"key":"1554_CR77","doi-asserted-by":"crossref","unstructured":"Ugarte-Gil MF, Mak A, Leong J, Dharmadhikari B, Kow NY, Re\u00e1tegui-Sokolova C, et al. Impact of glucocorticoids on the incidence of lupus-related major organ damage: a systematic literature review and meta-regression analysis of longitudinal observational studies. Lupus Sci Med. 2021;8:e000590.","DOI":"10.1136\/lupus-2021-000590"},{"key":"1554_CR78","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1146\/annurev-med-043021-032611","volume":"74","author":"S Lazar","year":"2023","unstructured":"Lazar S, Kahlenberg JM. Systemic lupus erythematosus: new diagnostic and therapeutic approaches. Annu Rev Med. 2023;74:339\u201352.","journal-title":"Annu Rev Med"},{"key":"1554_CR79","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1097\/BOR.0000000000001003","volume":"36","author":"H Kato","year":"2024","unstructured":"Kato H, Kahlenberg JM. Emerging biologic therapies for systemic lupus erythematosus. Curr Opin Rheumatol. 2024;36:169\u201375.","journal-title":"Curr Opin Rheumatol"},{"key":"1554_CR80","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1056\/NEJMoa1912196","volume":"382","author":"EF Morand","year":"2020","unstructured":"Morand EF, Furie R, Tanaka Y, Bruce IN, Askanase AD, Richez C, et al. Trial of anifrolumab in active systemic lupus erythematosus. N Engl J Med. 2020;382:211\u201321.","journal-title":"N Engl J Med"},{"key":"1554_CR81","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1136\/annrheumdis-2021-220920","volume":"81","author":"RA Furie","year":"2022","unstructured":"Furie RA, Aroca G, Cascino MD, Garg JP, Rovin BH, Alvarez A, et al. B-cell depletion with obinutuzumab for the treatment of proliferative lupus nephritis: a randomised, double-blind, placebo-controlled trial. Ann Rheum Dis. 2022;81:100\u20137.","journal-title":"Ann Rheum Dis"},{"key":"1554_CR82","doi-asserted-by":"crossref","unstructured":"Matos LC, Machado JP, Monteiro FJ, Greten HJ. Understanding traditional Chinese medicine therapeutics: an overview of the basics and clinical applications. Healthcare. 2021;9:257.","DOI":"10.3390\/healthcare9030257"},{"key":"1554_CR83","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1007\/s11655-024-3762-0","volume":"31","author":"BY Zhu","year":"2025","unstructured":"Zhu BY, Liu ZC, Zhao ZX, Huang HP, Zhang N, Xia J, et al. Pharmacological mechanism of Chinese medicine in systemic lupus erythematosus: a narrative review. Chin J Integr Med. 2025;31:157\u201369.","journal-title":"Chin J Integr Med"},{"key":"1554_CR84","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1016\/j.freeradbiomed.2019.08.013","volume":"143","author":"D Li","year":"2019","unstructured":"Li D, Qi J, Wang J, Pan Y, Li J, Xia X, et al. Protective effect of dihydroartemisinin in inhibiting senescence of myeloid-derived suppressor cells from lupus mice via Nrf2\/HO-1 pathway. Free Radic Biol Med. 2019;143:260\u201374.","journal-title":"Free Radic Biol Med"},{"key":"1554_CR85","doi-asserted-by":"publisher","first-page":"3221","DOI":"10.1007\/s00018-016-2223-0","volume":"73","author":"A Loboda","year":"2016","unstructured":"Loboda A, Damulewicz M, Pyza E, Jozkowicz A, Dulak J. Role of Nrf2\/HO-1 system in development, oxidative stress response and diseases: an evolutionarily conserved mechanism. Cell Mol Life Sci. 2016;73:3221\u201347.","journal-title":"Cell Mol Life Sci"},{"key":"1554_CR86","doi-asserted-by":"publisher","first-page":"3470","DOI":"10.4049\/jimmunol.1501785","volume":"196","author":"DW Beury","year":"2016","unstructured":"Beury DW, Carter KA, Nelson C, Sinha P, Hanson E, Nyandjo M, et al. Myeloid-derived suppressor cell survival and function are regulated by the transcription factor Nrf2. J Immunol. 2016;196:3470\u20138.","journal-title":"J Immunol"},{"key":"1554_CR87","doi-asserted-by":"publisher","first-page":"1702","DOI":"10.1007\/s11427-020-1840-1","volume":"64","author":"Z Lin","year":"2021","unstructured":"Lin Z, Liu Y, Chen L, Cao S, Huang Y, Yang X, et al. Artemisinin analogue SM934 protects against lupus-associated antiphospholipid syndrome via activation of Nrf2 and its targets. Sci China Life Sci. 2021;64:1702\u201319.","journal-title":"Sci China Life Sci"},{"key":"1554_CR88","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-019-1315-9","volume":"10","author":"J Yang","year":"2019","unstructured":"Yang J, Yang X, Yang J, Li M. Baicalin ameliorates lupus autoimmunity by inhibiting differentiation of Tfh cells and inducing expansion of Tfr cells. Cell Death Dis. 2019;10:140.","journal-title":"Cell Death Dis"},{"key":"1554_CR89","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1186\/s13075-019-1876-0","volume":"21","author":"D Li","year":"2019","unstructured":"Li D, Shi G, Wang J, Zhang D, Pan Y, Dou H, et al. Baicalein ameliorates pristane-induced lupus nephritis via activating Nrf2\/HO-1 in myeloid-derived suppressor cells. Arthritis Res Ther. 2019;21:105.","journal-title":"Arthritis Res Ther"},{"key":"1554_CR90","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.clim.2015.11.006","volume":"162","author":"J Liao","year":"2016","unstructured":"Liao J, Liu Y, Wu H, Zhao M, Tan Y, Li D, et al. The role of icaritin in regulating Foxp3\/IL17a balance in systemic lupus erythematosus and its effects on the treatment of MRL\/lpr mice. Clin Immunol. 2016;162:74\u201383.","journal-title":"Clin Immunol"},{"key":"1554_CR91","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1080\/08820139.2019.1698599","volume":"49","author":"X Zhou","year":"2020","unstructured":"Zhou X, Chen H, Wei F, Zhao Q, Su Q, Lei Y, et al. The Inhibitory effects of pentacyclic triterpenes from Loquat leaf against Th17 differentiation. Immunol Invest. 2020;49:632\u201347.","journal-title":"Immunol Invest"},{"key":"1554_CR92","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/2431617","volume":"2019","author":"X Zhou","year":"2019","unstructured":"Zhou X, Chen H, Wei F, Zhao Q, Su Q, Liang J, et al. 3\u03b2-Acetyloxy-oleanolic acid attenuates pristane-induced lupus nephritis by regulating Th17 differentiation. J Immunol Res. 2019;2019:2431617.","journal-title":"J Immunol Res"},{"key":"1554_CR93","doi-asserted-by":"publisher","first-page":"1951","DOI":"10.3389\/fimmu.2019.01951","volume":"10","author":"TJ Lin","year":"2019","unstructured":"Lin TJ, Wu CY, Tsai PY, Hsu WH, Hua KF, Chu CL, et al. Accelerated and severe lupus nephritis benefits from M1, an active metabolite of ginsenoside, by regulating NLRP3 inflammasome and T cell functions in mice. Front Immunol. 2019;10:1951.","journal-title":"Front Immunol"},{"key":"1554_CR94","doi-asserted-by":"publisher","DOI":"10.1016\/j.cbi.2024.110972","volume":"394","author":"T Yi","year":"2024","unstructured":"Yi T, Zhang W, Hua Y, Xin X, Wu Z, Li Y, et al. Rutin alleviates lupus nephritis by inhibiting T cell oxidative stress through PPAR\u03b3. Chem Biol Interact. 2024;394:110972.","journal-title":"Chem Biol Interact"},{"key":"1554_CR95","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2022.174808","volume":"919","author":"X Zhang","year":"2022","unstructured":"Zhang X, Zou M, Liang Y, Yang Y, Jing L, Sun M, et al. Arctigenin inhibits abnormal germinal center reactions and attenuates murine lupus by inhibiting IFN-I pathway. Eur J Pharmacol. 2022;919:174808.","journal-title":"Eur J Pharmacol"},{"key":"1554_CR96","first-page":"2097","volume":"15","author":"X Yu","year":"2018","unstructured":"Yu X, Zhang N, Lin W, Wang C, Gu W, Ling C, et al. Regulatory effects of four ginsenoside monomers in humoral immunity of systemic lupus erythematosus. Exp Ther Med. 2018;15:2097\u2013103.","journal-title":"Exp Ther Med"},{"key":"1554_CR97","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1038\/cmi.2015.13","volume":"13","author":"Y Wu","year":"2016","unstructured":"Wu Y, He S, Bai B, Zhang L, Xue L, Lin Z, et al. Therapeutic effects of the artemisinin analog SM934 on lupus-prone MRL\/lpr mice via inhibition of TLR-triggered B-cell activation and plasma cell formation. Cell Mol Immunol. 2016;13:379\u201390.","journal-title":"Cell Mol Immunol"},{"key":"1554_CR98","first-page":"2075","volume":"12","author":"Q Li","year":"2019","unstructured":"Li Q, Tan S, Xu K, Fu X, Yu J, Yang H, et al. Curcumin attenuates lupus nephritis in MRL\/lpr mice by suppressing macrophage-secreted B cell activating factor (BAFF). Int J Clin Exp Pathol. 2019;12:2075\u201383.","journal-title":"Int J Clin Exp Pathol"},{"key":"1554_CR99","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1053\/j.ajkd.2019.10.017","volume":"76","author":"SV Parikh","year":"2020","unstructured":"Parikh SV, Almaani S, Brodsky S, Rovin BH. Update on lupus nephritis: core curriculum 2020. Am J Kidney Dis. 2020;76:265\u201381.","journal-title":"Am J Kidney Dis"},{"key":"1554_CR100","doi-asserted-by":"publisher","first-page":"2028","DOI":"10.1681\/ASN.2010050472","volume":"21","author":"AS Bomback","year":"2010","unstructured":"Bomback AS, Appel GB. Updates on the treatment of lupus nephritis. J Am Soc Nephrol. 2010;21:2028\u201335.","journal-title":"J Am Soc Nephrol"},{"key":"1554_CR101","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1038\/s41572-019-0141-9","volume":"6","author":"HJ Anders","year":"2020","unstructured":"Anders HJ, Saxena R, Zhao MH, Parodis I, Salmon JE, Mohan C. Lupus nephritis. Nat Rev Dis Prim. 2020;6:7.","journal-title":"Nat Rev Dis Prim"},{"key":"1554_CR102","doi-asserted-by":"crossref","unstructured":"Seo Y, Mun CH, Park SH, Jeon D, Kim SJ, Yoon T, et al. Punicalagin ameliorates lupus nephritis via inhibition of PAR2. Int J Mol Sci. 2020;21:4975.","DOI":"10.3390\/ijms21144975"},{"key":"1554_CR103","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2022.115004","volume":"288","author":"Y Zhang","year":"2022","unstructured":"Zhang Y, Li Z, Wu H, Wang J, Zhang S. Esculetin alleviates murine lupus nephritis by inhibiting complement activation and enhancing Nrf2 signaling pathway. J Ethnopharmacol. 2022;288:115004.","journal-title":"J Ethnopharmacol"},{"key":"1554_CR104","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1177\/0961203316651738","volume":"26","author":"X Feng","year":"2017","unstructured":"Feng X, Chen W, Xiao L, Gu F, Huang J, Tsao BP, et al. Artesunate inhibits type I interferon-induced production of macrophage migration inhibitory factor in patients with systemic lupus erythematosus. Lupus. 2017;26:62\u201372.","journal-title":"Lupus"},{"key":"1554_CR105","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2019.152965","volume":"62","author":"WZ Dang","year":"2019","unstructured":"Dang WZ, Li H, Jiang B, Nandakumar KS, Liu KF, Liu LX, et al. Therapeutic effects of artesunate on lupus-prone MRL\/lpr mice are dependent on T follicular helper cell differentiation and activation of JAK2-STAT3 signaling pathway. Phytomedicine. 2019;62:152965.","journal-title":"Phytomedicine"},{"key":"1554_CR106","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.lfs.2018.07.009","volume":"208","author":"B Su","year":"2018","unstructured":"Su B, Ye H, You X, Ni H, Chen X, Li L. Icariin alleviates murine lupus nephritis via inhibiting NF-\u03baB activation pathway and NLRP3 inflammasome. Life Sci. 2018;208:26\u201332.","journal-title":"Life Sci"},{"key":"1554_CR107","doi-asserted-by":"publisher","first-page":"e0133724","DOI":"10.1371\/journal.pone.0133724","volume":"10","author":"Q Hu","year":"2015","unstructured":"Hu Q, Yang C, Wang Q, Zeng H, Qin W. Demethylzeylasteral (T-96) treatment ameliorates mice lupus nephritis accompanied by inhibiting activation of NF-\u03baB pathway. PLoS One. 2015;10:e0133724.","journal-title":"PLoS One"},{"key":"1554_CR108","doi-asserted-by":"publisher","first-page":"112799","DOI":"10.1016\/j.biopha.2022.112799","volume":"149","author":"YJ Wang","year":"2022","unstructured":"Wang YJ, Li YX, Li S, He W, Wang ZR, Zhan TP, et al. Progress in traditional Chinese medicine and natural extracts for the treatment of lupus nephritis. Biomed Pharmacother. 2022;149:112799.","journal-title":"Biomed Pharmacother"},{"key":"1554_CR109","unstructured":"2020 Chinese guidelines for the diagnosis and treatment of systemic lupus erythematosus. Zhonghua Nei Ke Za Zhi 2020;59:172\u201385."},{"key":"1554_CR110","unstructured":"Tang N, Zhou HX, Zhou DR. Meta-analysis of the efficacy of Tripterygium wilfordii preparations in the treatment of systemic lupus erythematosus in China. J Nanjing Xiaozhuang Univ. 2012;3:68\u201371."},{"key":"1554_CR111","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2023.117602","volume":"323","author":"D Li","year":"2024","unstructured":"Li D, Pan B, Ma N, Wang X, Deng X, Lai H, et al. Efficacy and safety of Shenqi Dihuang decoction for lupus nephritis: A systematic review and meta-analysis. J Ethnopharmacol. 2024;323:117602.","journal-title":"J Ethnopharmacol"},{"key":"1554_CR112","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1016\/j.joim.2020.08.007","volume":"18","author":"L Dai","year":"2020","unstructured":"Dai L, Chan KK, Mao JC, Tian Y, Gu JH, Zhou J, et al. Modified Zhibai Dihuang pill, a traditional Chinese medicine formula, on steroid withdrawal in systemic lupus erythematosus: A systematic review and meta-analysis. J Integr Med. 2020;18:478\u201391.","journal-title":"J Integr Med"},{"key":"1554_CR113","doi-asserted-by":"publisher","first-page":"e01548","DOI":"10.1128\/mBio.01548-14","volume":"5","author":"A Hevia","year":"2014","unstructured":"Hevia A, Milani C, L\u00f3pez P, Cuervo A, Arboleya S, Duranti S, et al. Intestinal dysbiosis associated with systemic lupus erythematosus. mBio. 2014;5:e01548\u201314.","journal-title":"mBio"},{"key":"1554_CR114","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.jtcme.2024.05.005","volume":"15","author":"Z Zhu","year":"2025","unstructured":"Zhu Z, Wang M, Huang L, He Z. Jieduquyuziyin prescription attenuates the side effect of prednisone through regulating gut microbiota when in the combination with prednisone treat MRL\/lpr mice. J Tradit Complementary Med. 2025;15:119\u201327.","journal-title":"J Tradit Complementary Med."}],"container-title":["Acta Pharmacologica Sinica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41401-025-01554-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41401-025-01554-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41401-025-01554-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T22:03:37Z","timestamp":1758751417000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41401-025-01554-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,17]]},"references-count":114,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["1554"],"URL":"https:\/\/doi.org\/10.1038\/s41401-025-01554-2","relation":{},"ISSN":["1671-4083","1745-7254"],"issn-type":[{"value":"1671-4083","type":"print"},{"value":"1745-7254","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,17]]},"assertion":[{"value":"30 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}